Clinical stability versus clinical failure in patients with community-acquired pneumonia

Seminars in Respiratory and Critical Care Medicine

Volumn 33, Issue 3, 2012, Pages 284-291

  Aliberti, Stefano ^a   Blasi, Francesco ^b  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

community acquired pneumonia; failure; nonresolving pneumonia; outcomes; stability

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN;

ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; COMMUNITY ACQUIRED PNEUMONIA; DRUG TREATMENT FAILURE; GENERAL CONDITION DETERIORATION; GENERAL CONDITION IMPROVEMENT; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION RISK; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; PNEUMONIA; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84862490578     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0032-1315640     Document Type: Article

References (37)

1. Ramirez JA. Community-Acquired Pneumonia: A Plan for Implementing National Guidelines at the Local Hospital Level. Philadelphia, PA Lippincott Williams & Wilkins: 2003
2. Ramirez JA, Vargas S, Ritter GW., et al. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia. Arch Intern Med: 1999; 159 20 2449 2454 (Pubitemid 29526773)
3. Halm EA, Fine MJ, Marrie TJ., et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines. JAMA: 1998; 279 18 1452 1457 (Pubitemid 28228202)
4. Niederman MS, Mandell LA, Anzueto A., et al. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med: 2001; 163 7 1730 1754 (Pubitemid 32578779)
5. Mandell LA, Wunderink RG, Anzueto A., et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis: 2007; 44 02 S27 S72 (Pubitemid 46290553)
6. Woodhead M, Blasi F, Ewig S., et al. European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J: 2006; 27 2 439
7. Lim WS, Baudouin SV, George RC., et al. Pneumonia Guidelines Committee of the BTS Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax: 2009; 64 03 iii1 iii55
8. Menéndez R, Martinez R, Reyes S., et al. Stability in community-acquired pneumonia: one step forward with markers? Thorax: 2009; 64 11 987 992
9. Menéndez R, Torres A, Rodríguez de Castro F., et al. Neumofail Group. Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients. Clin Infect Dis: 2004; 39 12 1783 1790 (Pubitemid 39657257)
10. Viale P, Scudeller L, Petrosillo N., et al. Clinical stability in human immunodeficiency virus-infected patients with community-acquired pneumonia. Clin Infect Dis: 2004; 38 2 271 279 (Pubitemid 38113037)
11. Christensen D, Feldman C, Rossi P., et al. Community-Acquired Pneumonia Organization Investigators. HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study. Clin Infect Dis: 2005; 41 4 554 556 (Pubitemid 41099654)
12. Arnold FW, Brock GN, Peyrani P., et al. CAPO authors. Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Respir Med: 2010; 104 11 1736 1743
13. Ramirez JA, Bordon J. Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia. Arch Intern Med: 2001; 161 6 848 850 (Pubitemid 32225393)
14. Athanassa Z, Makris G, Dimopoulos G, Falagas ME. Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis. Drugs: 2008; 68 17 2469 2481
15. Aliberti S, Peyrani P, Filardo G., et al. Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia. Chest: 2011; 140 2 482 488
16. Aliberti S, Blasi F, Zanaboni AM., et al. Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia. Eur Respir J: 2010; 36 1 128 134
17. Genné D, Kaiser L, Kinge TN, Lew D. Community-acquired pneumonia: causes of treatment failure in patients enrolled in clinical trials. Clin Microbiol Infect: 2003; 9 9 949 954 (Pubitemid 37236162)
18. Arancibia F, Ewig S, Martinez JA., et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med: 2000; 162 1 154 160 (Pubitemid 30469813)
19. Genné D, Sommer R, Kaiser L., et al. Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis: 2006; 25 3 159 166
20. Hoogewerf M, Oosterheert JJ, Hak E, Hoepelman IM, Bonten MJ. Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia. Clin Microbiol Infect: 2006; 12 11 1097 1104 (Pubitemid 44462844)
21. Aliberti S, Amir A, Peyrani P., et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest: 2008; 134 5 955 962
22. Ott SR, Hauptmeier BM, Ernen C., et al. Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis. Eur Respir J: 2012; 39 3 611 618
23. Rosón B, Carratalà J, Fernández-Sabé N, Tubau F, Manresa F, Gudiol F. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia. Arch Intern Med: 2004; 164 5 502 508 (Pubitemid 38314445)
24. Menéndez R, Cavalcanti M, Reyes S., et al. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax: 2008; 63 5 447 452 (Pubitemid 351692355)
25. Hess G, Hill JW, Raut MK., et al. Comparative antibiotic failure rates in the treatment of community-acquired pneumonia: results from a claims analysis. Adv Ther: 2010; 27 10 743 755
26. Kaye KS, Harris AD, McDonald JR, Strausbaugh LJ, Perencevich E.; Infectious Diseases Society of America Emerging Infections Network. Measuring acceptable treatment failure rates for community-acquired pneumonia: potential for reducing duration of treatment and antimicrobial resistance. Infect Control Hosp Epidemiol: 2008; 29 2 137 142 (Pubitemid 351269209)
27. Ye X, Sikirica V, Schein JR., et al. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis. Clin Ther: 2008; 30 2 358 371 (Pubitemid 351474372)
28. Menéndez R, Torres A, Zalacaín R., et al. Neumofail Group. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax: 2004; 59 11 960 965 (Pubitemid 39490781)
29. Mortensen EM, Coley CM, Singer DE., et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med: 2002; 162 9 1059 1064 (Pubitemid 34492537)
30. Ramirez J, Aliberti S, Mirsaeidi M., et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis: 2008; 47 2 182 187 (Pubitemid 351920618)
31. Singanayagam A, Singanayagam A, Elder DH, Chalmers JD. Is community-acquired pneumonia an independent risk factor for cardiovascular disease? Eur Respir J: 2012; 39 1 187 196
32. Corrales-Medina VF, Suh KN, Rose G., et al. Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS Med: 2011; 8 6 e1001048
33. Garcia-Vidal C, Carratalà J. Early and late treatment failure in community-acquired pneumonia. Semin Respir Crit Care Med: 2009; 30 2 154 160
34. Menéndez R, Torres A, Zalacaín R., et al. NEUMOFAIL Group. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med: 2005; 172 6 757 762 (Pubitemid 41324232)
35. Low DE, Mazzulli T, Marrie T. Progressive and nonresolving pneumonia. Curr Opin Pulm Med: 2005; 11 3 247 252 (Pubitemid 40577177)
36. Kyprianou A, Hall CS, Shah R, Fein AM. The challenge of nonresolving pneumonia: knowing the norms of radiographic resolution is key. Postgrad Med: 2003; 113 1 79 82, 85-88, 91-92
37. Salomoni G, Aliberti S, Travierso C., et al. Incidence, risk factors and outcomes of nonresolving pneumonia. Paper presented at: European Respiratory Society Annual Congress; September 18-22, 2010; Barcelona, Spain